Business
Trading Update
Elementis plc announced a resilient trading performance for the year ended 31 December 2025, with revenues expected to be in line with market consensus of $600m and adjusted operating profit marginally ahead of consensus, which stood at $125m. The company anticipates improved adjusted operating margins compared to the previous year, driven by its Elevate Elementis strategy, operational efficiencies, the acquisition of Alchemy Ingredients Limited for $22m, and ongoing cost savings. Net debt is projected to be approximately $185m, reflecting a £40m share buyback, an $11m disposal of a disused site, and the Alchemy acquisition. Disclaimer*

About this update from Elementis Plc
[{"type":"text","content":"\n\n21 January 2026\n \n \nElementis plc\nTrading Update\n \nResilient performance in challenging markets\nTrading marginally ahead of full year expectations\n \nElementis plc (\"Elementis\" or the \"Group\"), a global specialty chemicals company, today issues its scheduled trading update for the three months and year ended 31 December 2025.\nElementis will publish its results for the financial year to 31 December 2025 on 5 March 2026.\nBusiness performance\nThe Group has delivered a resilient performance with Revenues1 expected to be in line with market consensus2, despite the ongoing challenging market conditions.\nFull year Group Adjusted operating profit1 is expected to be marginally ahead of market consensus2, with Adjusted operating margins1 ahead of last year. The improved margin performance has been driven by the benefits of our Elevate Elementis strategy and the positive changes being implemented across the Group, as we look to build on our strong foundations. These include: the simplification of our operational structure to enhance efficiency and agility, the bolt-on acquisition of UK based Alchemy Ingredients Limited (\"Alchemy\") in November 2025, as well as the ongoing delivery of our previously announced cost savings targets.\nBalance sheet strength\nThe Group continues to generate positive free cash flow that gives us balance sheet strength and future capital allocation optionality.\nNet debt pre IFRS 16 basis at the end of the financial year 2025 is expected to be c.$185m. This reflects several one-off cash payments during the year including: the successful completion of the Group's first share buyback programme for a total consideration of £40m (c.$54m), the previously announced disposal of the disused manufacturing site and associated environmental liabilities at Eaglescliffe, UK, for $11m, and the acquisition of Alchemy for $22m.\nChair succession\nFurther to the announcement on 29 October 2025, the Chair succession process continues to progress and an update will be provided in due course.\n \n \nEnquiries\nInvestors: Zeeshan Maqbool, Elementis plc Tel: +44 (0) 7553 340380\nPress: Martin Robi...